Sign Up to like & get
recommendations!
1
Published in 2023 at "Clinical pharmacology in drug development"
DOI: 10.1002/cpdd.1251
Abstract: Proton pump inhibitors (PPIs) differ in onset of action and bioavailability. This trial was conducted to investigate the pharmacokinetics and pharmacodynamics of an immediate-release capsule formulation containing lansoprazole 30 mg and sodium bicarbonate 1100 mg (T preparation)…
read more here.
Keywords:
lansoprazole sodium;
single multiple;
pharmacokinetics pharmacodynamics;
preparation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.766
Abstract: ASP8062 is an orally active γ‐amino‐butyric acid type B (GABAB) receptor positive allosteric modulator currently in phase 2 development. Safety and pharmacokinetic (PK) profiles of ASP8062 were evaluated in 2 studies in healthy subjects. The…
read more here.
Keywords:
profiles asp8062;
pharmacokinetic profiles;
safety;
single multiple ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Pharmacology"
DOI: 10.1002/jcph.1119
Abstract: Verinurad (RDEA3170) is a selective uric acid reabsorption inhibitor in clinical development for treatment of hyperuricemia and gout. This phase 1b, multiple‐dose, drug‐drug interaction study evaluated the pharmacokinetics, pharmacodynamics, and tolerability of verinurad in combination…
read more here.
Keywords:
verinurad allopurinol;
verinurad;
multiple dose;
pharmacodynamics tolerability ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2021.01.005
Abstract: PURPOSE Ranolazine, an inhibitor of late inward sodium current, is an antianginal agent. In this study, the pharmacokinetic (PK) properties and tolerability of single- and multiple-dose ranolazine were compared between healthy Koreans and Caucasians. METHODS…
read more here.
Keywords:
ranolazine;
difference;
koreans caucasians;
safety ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2021.04.014
Abstract: PURPOSE For neuropathic pain, current therapies do not provide relief for most patients; less than half achieve a 50% pain reduction. Current analgesics have adverse effects. We present 2 Phase I studies of LX9211, a…
read more here.
Keywords:
lx9211;
controlled studies;
placebo controlled;
multiple dose ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2021.09.019
Abstract: PURPOSE This study reports data from the first evaluation of etelcalcetide treatment in Chinese adults with chronic kidney disease and secondary hyperparathyroidism. METHODS This phase I, randomized study compared thrice-weekly etelcalcetide (5 mg per dose…
read more here.
Keywords:
etelcalcetide administered;
chronic kidney;
treatment;
study ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "European Neuropsychopharmacology"
DOI: 10.1016/j.euroneuro.2019.05.009
Abstract: ACT-541468 is a dual orexin receptor antagonist with sleep-promoting effects in humans. Following entry-into-humans, its pharmacokinetics (PK) including dose-proportionality and accumulation, pharmacodynamics (PD), safety, and tolerability following multiple-ascending oral dose (MAD) administration in the morning,…
read more here.
Keywords:
evening administration;
pharmacology;
act 541468;
multiple dose ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Pharmaceutical Biology"
DOI: 10.1080/13880209.2021.1928716
Abstract: Abstract Context Co-administration between warfarin (WF) and Curcuma xanthorrhiza Roxb. (Zingiberaceae) (CX) is found in Indonesian patients and need to be evaluated. Objective This study assesses the effect of concomitant administration of CX extract on…
read more here.
Keywords:
day;
administration;
curcuma xanthorrhiza;
multiple dose ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceutical Biology"
DOI: 10.1080/13880209.2022.2087688
Abstract: Abstract Context Ginkgo leaf tablet (GLT), a traditional Chinese herbal formula, is often combined with rosiglitazone (ROS) for type 2 diabetes mellitus treatment. However, the drug-drug interaction between GLT and ROS remains unknown. Objective To…
read more here.
Keywords:
leaf tablet;
dose glt;
multiple dose;
ginkgo leaf ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Clinical Toxicology"
DOI: 10.1080/15563650.2023.2165502
Abstract: Thallium poisoning is rare but associated with considerable morbidity and mortality, with lethal doses reported between 8 and 12mg/kg [1]. We report a case of full recovery following treatment of an ingestion of thallium sulfate…
read more here.
Keywords:
day;
thallium;
thallium sulfate;
multiple dose ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofaa034
Abstract: Abstract Background Few published studies exist to describe the off-label use of multiple-dose fosfomycin for outpatient treatment of complicated urinary tract infections (UTI). The purpose of this study was to characterize the patients, infections, drug…
read more here.
Keywords:
resolution;
dose fosfomycin;
treatment;
multiple dose ... See more keywords